An Alpaca Nanobody Inhibits Hepatitis C Virus Entry And Cell-To-Cell Transmission

Abstract

This is the first description of a potent and broadly neutralizing HCV-specific nanobody representing a significant advance that will lead to future development of novel entry inhibitors for the treatment and prevention of HCV infection and help our understanding of HCV cell-to-cell transmission.